Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Inj.bupivacaine , inj buprenorphine: 30ml of 0.5%inj bupivacaine (150mg) and inj. Buprenorphine 150 mcg is injected with an 10ml syringe at the brachial plexus after identifying the br
Sponsors
JSS Academy of Higher Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: - Age between 18 years-60 years - ASA-PS I and II - Posted for upper limb surgeries
Exclusion criteria
Exclusion criteria: -Patient not giving consent -Coagulopathy -Neuropathy -Pregnancy -Hemodynamic instability -Allergic history to local anesthetic -Local infection, open wound , distorted anatomy in the affected side of neck and supraclavicular area due to hematoma, swelling
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effect of block and duration of analgesia by adding adjuvant buprenorphine to bupivacaine and levobupivacaineTimepoint: From giving supraclavicular brachial plexus block to 24 hours postoperative period | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine onset and duration of sensory block using Holmen scale, to determine onset and duration of motor block using modified bromage scale, to determine total duration of postoperative analgesia using VAS score, any side effects like nausea, vomiting, pruritis, respiratory depressionTimepoint: From giving supraclavicular brachial plexus block to 24 hours postoperative period | — |
Countries
India
Contacts
Public ContactDr. Manjula BP
JSS Academy of Higher Education and Research
Outcome results
None listed